Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. M. (Marco) de Bruyn

Publicaties

Vvax001, a Therapeutic Vaccine for Patients with HPV16-positive High-grade Cervical Intraepithelial Neoplasia: a Phase II Trial

128P - Whole blood transcriptomics identifies transcriptional patterns linked to outcomes in patients receiving immune checkpoint inhibitors

B cells critical for outcome in high grade serous ovarian carcinoma

Biomarker and transcriptomics profiles of serum selenium concentrations in patients with heart failure are associated with immunoregulatory processes

Correction to: Prediction of recurrence risk in endometrial cancer with multimodal deep learning (Nature Medicine, (2024), 10.1038/s41591-024-02993-w)

Genomic instability as a driver and suppressor of anti-tumor immunity

Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer

ImmunoPET provides a novel way to visualize the CD103+ tissue-resident memory T cell to predict the response of immune checkpoint inhibitors.

Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study

Prediction of recurrence risk in endometrial cancer with multimodal deep learning

Lees meer

Pers/media